Drug Name EVUSHELD (tixagevimab with cilgavimab) Drug Class Vaccine Risk minimization type Direct Healthcare Professional Communication DHPC Healthcare provider guide patient guide Specialty (Theraputic area) Immunology Risk Updated dosage recommendations for EVUSHELD (tixagevimab co-packaged with cilgavimab) for pre-exposure prophylaxis against COVID-19 High-risk cardiac patients and the use of EVUSHELD (tixagevimab co packaged with cilgavimab) risk of cardiovascular events patient guide Health care provider guide Dear Healthcare provider letter DHPC